Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China 2022-04-04 08:30
Innovent Releases Results of a Phase 3 Clinical Study of IBI306 (PCSK-9 inhibitor) in Chinese Patients with Heterozygous Familial Hypercholesterolemia at the American College of Cardiology Annual Congress 2022 2022-04-04 08:00
Commercial Launch: Illuccix® Now Available to Order in the United States 2022-04-04 07:06
Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting 2022-04-01 23:45
Zhongze Therapeutics Announces Successful Completion Of The First-In-Human Dose Escalation Study of ZZ6398 in Healthy Volunteers 2022-04-01 16:55
Zhimeng Biopharma Announces Dosing of First Subject in First-in-Human Phase -- Clinical Trial of CB06 2022-03-31 23:40
I-Mab Announces Voluntary Lock-ups by Key Shareholders and Senior Management for Long-Term Commitment 2022-03-31 20:00
Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17) 2022-03-31 18:00
Airway Therapeutics Announces First Patient Dosed in Phase 1b Trial of AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD) 2022-03-31 17:00
CBC Group-backed Hasten Biopharma successfully completes acquisition of five cardiovascular and metabolism drugs from Takeda 2022-03-31 15:05
CStone announces first patient enrollment in the U.S. in the Phase 1 clinical trial of CS5001, a potential global best-in-class ROR1-targeting ADC 2022-03-31 08:02
LifeTech Scientific Corporation（1302.HK） Announces 2021 Annual Results 2022-03-31 03:27
Symbiance announces the launch of SimpleStats, an application for statistical analysis and reporting of clinical data 2022-03-30 21:00
GenScript Receives "Best Contract Development and Manufacturing Organization Award" For the Third Time in a Row 2022-03-30 17:30
BioVaxys Expands Cancer Vaccine Platform 2022-03-30 16:02
Qiming's Portfolio Company Rendu Biotechnology Lists on STAR Market 2022-03-30 10:22
Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes 2022-03-30 09:00
RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines 2022-03-30 08:31
Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China 2022-03-30 08:05
Biosion licenses BSI-060T (anti-Siglec-15) to Pyxis Oncology 2022-03-29 23:00
1 147 148 149 150 151 415